Success Metrics

Clinical Success Rate
100.0%

Based on 6 completed trials

Completion Rate
100%(6/6)
Active Trials
0(0%)
Results Posted
17%(1 trials)

Phase Distribution

Ph phase_2
2
20%
Ph not_applicable
1
10%
Ph phase_3
2
20%
Ph phase_4
3
30%

Phase Distribution

0

Early Stage

2

Mid Stage

5

Late Stage

Phase Distribution8 total trials
Phase 2Efficacy & side effects
2(25.0%)
Phase 3Large-scale testing
2(25.0%)
Phase 4Post-market surveillance
3(37.5%)
N/ANon-phased studies
1(12.5%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(6)
Terminated(2)
Other(2)

Detailed Status

Completed6
Withdrawn2
unknown2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 22 (25.0%)
Phase 32 (25.0%)
Phase 43 (37.5%)
N/A1 (12.5%)

Trials by Status

completed660%
withdrawn220%
unknown220%

Recent Activity

0 active trials
Showing 5 of 10
withdrawnnot_applicable

A Multicenter Analysis of Levonorgestrel-Intrauterine System (LNG-IUS) Use in the Postpartum Period

NCT01161095
unknown

Uterine Artery Doppler and Menstrual Changes After Insertion Intrauterine Contraceptive Device

NCT05986344
withdrawn

Adenomyosis: Genomic Mechanisms and Biological Response

NCT03428854
completedphase_2

LNG-IUS for Treatment of Dysmenorrhea

NCT01601366
completedphase_4

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

NCT02534688
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT01161095Not Applicable

A Multicenter Analysis of Levonorgestrel-Intrauterine System (LNG-IUS) Use in the Postpartum Period

Withdrawn
NCT05986344

Uterine Artery Doppler and Menstrual Changes After Insertion Intrauterine Contraceptive Device

Unknown
NCT03428854

Adenomyosis: Genomic Mechanisms and Biological Response

Withdrawn
NCT01601366Phase 2

LNG-IUS for Treatment of Dysmenorrhea

Completed
NCT02534688Phase 4

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

Completed
NCT02894151Phase 2

Effectiveness of Levonorgestrel-intrauterine System (LNG-IUS) Versus Depot Medroxyprogesterone Acetate (DMPA) in Treatment of Pelvic Pain in Clinically Diagnosed Endometriotic Patients

Completed
NCT01392157Phase 4

Acceptability and Continuation Rate of Implanon in a Brazilian Public Sector

Completed
NCT01388582Phase 4

The Effect of Hormonal Contraceptives on Breast-milk Production and Infant Growth

Completed
NCT01125488Phase 3

Maintenance Therapy of Levonorgestrel-releasing Intrauterine System (LNG-IUS) to Prevent the Recurrence of Symptomatic Endometriosis After Conservative Surgery

Unknown
NCT00966264Phase 3

Hysterectomy and Levonorgestrel Releasing Intrauterine System (LNG-IUS) in the Treatment of Menorrhagia

Completed

All 10 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
10